Patent ID: 11358939

Abstract:
The invention relates to novel compounds that are derivatives of 1,4-benzodiazepin-2-one, having the general formula I:           R5=o-, m-, p-COCH3, Cl, F, Br, NO2, CF3;       R5=m-, p-COCH3, o-, m-, p-F, Br, CF3;       R5=o-, m-, p-COCH3, Cl, F, Br, NO2, CF3;       R5=o-, m-, p-COCH3, Cl, F, Br, NO2, CF3;       R5=o-, m-, p-COCH3, Cl, F, Br, NO2, CF3  and the use of said compounds in the field of medicine as analgesics, anorexigenic or orexigenic agents for weight regulation (loss or gain), antidepressants and anxiolytics for treating psychological disorders, and also antihypoxic and nootropic agents for the prophylaxis and treatment of central nervous system disorders.